Skip to Main Content

Author Details

Aykut Uren
Georgetown University Medical Center
1991
124
39
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36805500Lymphocyte antigen 6K signaling to aurora kinase promotes advancement of the cell cycle and the growth of cancer cells, which is inhibited by LY6K-NSC243928 interaction.Cancer Lett2023
37732905Piperacetazine Directly Binds to the PAX3::FOXO1 Fusion Protein and Inhibits Its Transcriptional Activity.Cancer Res Commun2023
36805500Lymphocyte antigen 6K signaling to aurora kinase promotes advancement of the cell cycle and the growth of cancer cells, which is inhibited by LY6K-NSC243928 interaction.Cancer Lett2023
36917882Design, synthesis and biological evaluation of Nucleosidic CD99 inhibitors that selectively reduce Ewing sarcoma viability.Eur J Med Chem2023
37732905Piperacetazine Directly Binds to the PAX3::FOXO1 Fusion Protein and Inhibits Its Transcriptional Activity.Cancer Res Commun2023
36917882Design, synthesis and biological evaluation of Nucleosidic CD99 inhibitors that selectively reduce Ewing sarcoma viability.Eur J Med Chem2023
35047826Comprehensive profiling of mRNA splicing indicates that GC content signals altered cassette exon inclusion in Ewing sarcoma.NAR Cancer2022
33533702Healthcare related aversion and care seeking patterns of female aviators in the United States.Arch Environ Occup Health2022
35047826Comprehensive profiling of mRNA splicing indicates that GC content signals altered cassette exon inclusion in Ewing sarcoma.NAR Cancer2022
33533702Healthcare related aversion and care seeking patterns of female aviators in the United States.Arch Environ Occup Health2022
33419969YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells.Oncogenesis2021
33676410SPRD: a surface plasmon resonance database of common factors for better experimental planning.BMC Mol Cell Biol2021
34183356Stress-Mediated Reprogramming of Prostate Cancer One-Carbon Cycle Drives Disease Progression.Cancer Res2021
34133426Clofarabine induces ERK/MSK/CREB activation through inhibiting CD99 on Ewing sarcoma cells.PLoS One2021
33419969YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells.Oncogenesis2021
33676410SPRD: a surface plasmon resonance database of common factors for better experimental planning.BMC Mol Cell Biol2021
34133426Clofarabine induces ERK/MSK/CREB activation through inhibiting CD99 on Ewing sarcoma cells.PLoS One2021
34183356Stress-Mediated Reprogramming of Prostate Cancer One-Carbon Cycle Drives Disease Progression.Cancer Res2021
32043806Covalent Complex of DNA and Bacterial Topoisomerase: Implications in Antibacterial Drug Development.ChemMedChem2020
32016454Development of an Ewing sarcoma cell line with resistance to EWSâ¿¿FLI1 inhibitor YKâ¿¿4â¿¿279.Mol Med Rep2020
32098321Small Molecule Binds with Lymphocyte Antigen 6K to Induce Cancer Cell Death.Cancers (Basel)2020
32043806Covalent Complex of DNA and Bacterial Topoisomerase: Implications in Antibacterial Drug Development.ChemMedChem2020
32016454Development of an Ewing sarcoma cell line with resistance to EWSâ¿¿FLI1 inhibitor YKâ¿¿4â¿¿279.Mol Med Rep2020
32098321Small Molecule Binds with Lymphocyte Antigen 6K to Induce Cancer Cell Death.Cancers (Basel)2020
30655325Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma.Mol Cancer Res2019
31572348Targeting the Non-catalytic RVxF Site of Protein Phosphatase-1 With Small Molecules for Ebola Virus Inhibition.Front Microbiol2019
30655325Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma.Mol Cancer Res2019
31238994Helix-A peptide prevents gp120-mediated neuronal loss.Mol Brain2019
31406155Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.Cell Death Dis2019
31315662Identification of undecylenic acid as EAG channel inhibitor using surface plasmon resonance-based screen of KCNH channels.BMC Pharmacol Toxicol2019
31312022Regulation of the unfolded protein response through ATF4 and FAM129A in prostate cancer.Oncogene2019
31392992EWS-FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex.Nucleic Acids Res2019
31306268Pilots' Healthcare Seeking Anxiety When Experiencing Chest Pain.J Occup Environ Med2019
31238994Helix-A peptide prevents gp120-mediated neuronal loss.Mol Brain2019
31406155Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.Cell Death Dis2019
31315662Identification of undecylenic acid as EAG channel inhibitor using surface plasmon resonance-based screen of KCNH channels.BMC Pharmacol Toxicol2019
31572348Targeting the Non-catalytic RVxF Site of Protein Phosphatase-1 With Small Molecules for Ebola Virus Inhibition.Front Microbiol2019
31312022Regulation of the unfolded protein response through ATF4 and FAM129A in prostate cancer.Oncogene2019
31392992EWS-FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex.Nucleic Acids Res2019
31306268Pilots' Healthcare Seeking Anxiety When Experiencing Chest Pain.J Occup Environ Med2019
29651165The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer.Cell Death Differ2018
30169869Protein Phosphatase 1-Targeting Small-Molecule C31 Inhibits Ebola Virus Replication.J Infect Dis2018
30002427Investigating molecular interactions between oxidized neuroglobin and cytochrome c.Sci Rep2018
30374109Fibroblast Growth Factor Binding Protein 3 (FGFBP3) impacts carbohydrate and lipid metabolism.Sci Rep2018
29901186Early synergistic interactions between the HPV16⿿E7 oncoprotein and 17β-oestradiol for repressing the expression of Granzyme B in a cervical cancer model.Int J Oncol2018
30038364Correction: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.Cell Death Dis2018
29382926Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99.Oncogene2018
29651165The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer.Cell Death Differ2018
30002427Investigating molecular interactions between oxidized neuroglobin and cytochrome c.Sci Rep2018
30038364Correction: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.Cell Death Dis2018
  • 1 - 50 of 248

Recommended Authors

Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year 2010
Number of shared co-authors 0
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 6
Anupama E Gururaj
National Institute of Allergy and Infectious Disease, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 0
Limei Hu
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 0
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 6
Christopher D Willey
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 1
Stephane Angers
Department of Pharmaceutical Sciences, University of Toronto
Career Start Year 1999
Number of shared co-authors 2
Jan Koster
Amsterdam University Medical Centers location AMC
Career Start Year 1999
Number of shared co-authors 11
Krishna P Bhat
Department of Neurosurgery at the University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Chun-Liang Chen
National Dong Hwa University
Career Start Year 1997
Number of shared co-authors 1
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 16
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 3
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 4
Theresa M LaVallee
Parker Institute for Cancer Immunotherapy
Career Start Year 1996
Number of shared co-authors 0
Krister Wennerberg
University of Copenhagen
Career Start Year 1994
Number of shared co-authors 3
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 13
Dirk Geerts
Amsterdam University Medical Center
Career Start Year 1989
Number of shared co-authors 0
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 1
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 4
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 9
Choh Yeung
Center for Cancer Research, National Cancer Institute
Career Start Year 1987
Number of shared co-authors 11
Charles L Sawyers
Memorial Sloan Kettering Cancer Center
Career Start Year 1986
Number of shared co-authors 8
David D L Bowtell
Peter MacCallum Cancer Centre
Career Start Year 1983
Number of shared co-authors 1
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 2
John A Copland
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 1
Francisca Vazquez
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 2
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 5
Frank McCormick
Frederick National Laboratory for Cancer Research
Career Start Year 1975
Number of shared co-authors 3

Collaborators

Jeffrey A Toretsky
Georgetown University Medical Center, Georgetown University
Co-authored papers 45
Hayriye V Erkizan
Co-authored papers 14
Garrett T Graham
Co-authored papers 9
Heinrich Kovar
St. Anna Children's Cancer Research Institute (CCRI), Medical University Vienna
Co-authored papers 9
Saravana P Selvanathan
Co-authored papers 7
Richard Moriggl
Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna
Co-authored papers 6
Ogan D Abaan
Illumina Inc.
Co-authored papers 5
Bhaskar Kallakury
Georgetown University
Co-authored papers 5
G??nther H S Richter
Children's Cancer Research Center
Co-authored papers 4
Maksymilian Chruszcz
University of South Carolina, Michigan State University
Co-authored papers 4
Eleni M Tomazou
St. Anna Children's Cancer Research Institute (CCRI)
Co-authored papers 4
Maximilian Kauer
St. Anna Children's Cancer Research Institute (CCRI)
Co-authored papers 4
Peter J Houghton
The University of Texas Health Science Center at San Antonio
Co-authored papers 3
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Uta Dirksen
University Hospital Essen, West German Cancer Center
Co-authored papers 3
Marc Wiedner
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 3
Chand Khanna
National Cancer Institute, National Institutes of Health
Co-authored papers 3
Takuro Nakamura
Tohoku University Graduate School of Medicine
Co-authored papers 2
Elizabeth R Lawlor
Seattle Children's Research Institute
Co-authored papers 2
Alfredo Hidalgo-Miranda
Co-authored papers 2
Ladan Fazli
University of British Columbia
Co-authored papers 2
Franck Tirode
Cancer Center of Lyon
Co-authored papers 2
Kimberly Stegmaier
Dana-Farber Cancer Institute
Co-authored papers 2
Beat W Sch??fer
Department of Oncology and Children's Research Center, University Children's Hospital
Co-authored papers 2
Olivier Delattre
PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie
Co-authored papers 2
William Matsui
Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin
Co-authored papers 2
Amrita K Cheema
Co-authored papers 2
Katia Scotlandi
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 2
Branka Radic-Sarikas
St. Anna Children's Cancer Research Institute (CCRI), Medical University of Vienna
Co-authored papers 2
E Alejandro Sweet-Cordero
University of California San Francisco
Co-authored papers 2
Release 1.2